CCP
RMD icon

Corient Capital Partners’s ResMed RMD Stock Holding History

Corient Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$671K Hold
3,199
– – 0.05% 278
2022
Q2 		$671K Buy
3,199
+416
+15% +$88.6K 0.05% 291
2022
Q1 		$675K Buy
2,783
+237
+9% +$57.3K 0.04% 326
2021
Q4 		$663K Buy
2,546
+7
+0.3% +$1.82K 0.04% 313
2021
Q3 		$669K Buy
2,539
+119
+5% +$32.5K 0.05% 294
2021
Q2 		$597K Buy
2,420
+228
+10% +$47.9K 0.04% 321
2021
Q1 		$426K Buy
2,192
+38
+2% +$7.62K 0.04% 353
2020
Q4 		$457K Buy
2,154
+148
+7% +$29.5K 0.05% 288
2020
Q3 		$344K Sell
2,006
-86
-4% -$15.9K 0.04% 313
2020
Q2 		$402K Buy
2,092
+197
+10% +$32.2K 0.05% 284
2020
Q1 		$279K Buy
+1,895
New +$302K 0.04% 306

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Corient Capital Partners's RMD Position: Q3 2022 in Review

Corient Capital Partners held its ResMed (RMD) position steady in Q3 2022 at 3,199 shares worth $671K. The position accounts for 0.05% of the portfolio, ranked #278.

Corient Capital Partners first reported a position in RMD in Q1 2020 and has held it in 11 quarters since. The position peaked at $675K in Q1 2022. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Corient Capital Partners held 3,199 shares of ResMed worth $671K as of Q3 2022.
  • Corient Capital Partners left its ResMed share count unchanged in Q3 2022.
  • ResMed made up 0.05% of Corient Capital Partners's portfolio in Q3 2022, its #278 holding.
  • Corient Capital Partners first reported a position in ResMed in Q1 2020 and has held it in 11 quarters since.
  • Corient Capital Partners's ResMed position peaked at $675K in Q1 2022.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.